Cigna, Anthem dispute bills after failed merger

A proposed merger between two major health insurance providers ended in a messy breakup after antitrust issues prohibited the roughly $50 billion transaction in 2017. Now, the two companies, Anthem and Cigna, are still disputing which company will foot the costs of the failed deal, Bloomberg Quint reported.

The two companies have been feuding in court since 2017, with Cigna asking for a total of $15 billion in damages, including the $1.85 billion fee after the merger fell apart. Anthem also filed a dueling lawsuit to pursue damages from the split, arguing it should be owed $20 billion after Cigna sabotaged the deal.

“The case provides a look at one of the largest corporate deals in the U.S. to go sour and a courtroom version of the blame game,” Bloomberg reported.

A Delaware judge will start to settle the issue this week.

Since the merger meltdown, Cigna went on to acquire Express Scripts for $67 billion. Meanwhile, Anthem has taken more of a backseat in mergers and acquisition.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.